The biological activity of polyoma viral DNA was evaluated in mice and hamsters. Viral DNA administered parenterally is about 4 to 5 logs less efficient than polyoma virions in establishing infection in mice. Supercoiled viral DNA was infectious for mice after parenteral administration, giving mean infective doses of 10-3 to 10-4 ,ig. However, animals fed microgram quantities of polyoma DNA I did not become infected. Linearization of viral DNA with R * EcoRI or R. BamHI, which are single-cut enzymes cleaving in the early and late regions of the genome, respectively, reduced the infectivity for mice approximately fivefold. Approximately 10% of newborn hamsters inoculated intraperitoneally with polyoma DNA I developed tumors. In contrast, the same amount of viral DNA which had been cleaved in the early region with R .EcoRI induced tumors in 50% of inoculated hamsters.
The majority of animal viral DNAs are known to be infectious for tissue culture cells (9, 13) , and in the case of many oncogenic viruses, such as simian virus 40 (SV40) and polyoma virus (PY), purified DNA is capable of transforming cells in culture (6, 8) . The development of techniques to enhance both the infectivity (24) and transforming ability (2) of viral DNA has further facilitated study of the biological activity of various forms of viral DNA (1, 19) in permissive and nonpermissive tissue culture cell systems. Much less is known about the biological activity of viral DNA after its inoculation into animals. Ito (20) reported that intradermal inoculation of DNA extracted from papillomatous tissue of wild cottontail rabbits could induce tumors at the inoculation site. Atanasiu and colleagues (3, 27) reported inducing tumors in hamsters by subcutaneous inoculation of DNA extracted from mouse embryo cell cultures infected with PY. DNAs extracted from SV40 (4) , bovine papilloma virus (5), simian adenovirus type 7 (7), and oncogenic primate herpesviruses (11) have also been shown to be tumorigenic. Mayne et al. (25) demonstrated that simian adenovirus type 7 DNA fragmented by mechanical shearing retained its ability to induce tumors.
More recently, Sol and van der Noorda (34) found that 11 of 33 newborn hamsters injected with 1 to 2 ,ug of SV40 DNA I developed tumors during a 6-month observation period. A similar proportion of animals (5/17) injected with R.
EcoRI-cleaved SV40 DNA also developed tumors. One of these DNA-induced tumors was established in tissue culture and shown to have SV40 T antigen and rescuable SV40.
Mice are known to be highly sensitive to infection by parenterally inoculated PY; a single tissue culture infectious dose is sufficient to initiate an infection that leads to antibody formation (30) . Testing inoculated mice for serum hemagglutination-inhibiting (HI) antibodies, the so-called MAP (mouse antibody production) test (30) , provides a simple and unambiguous assay for PY infection. In contrast to tumor induction assays in mice, which require inoculation of newborn animals, the infection detected by the MAP test is not age dependent.
To better define the biological activity of viral DNA in animals, we have studied the ability of PY DNA to initiate productive infection in weanling mice, as measured by the MAP test, and to induce tumors in newborn hamsters. Whereas the mouse system constitutes an in vivo test for productive infection, tumor induction in suckling hamsters provides an in vivo equivalent of a transformation assay. Although we found mice to be highly sensitive to parenterally adminstered PY DNA, we were unable to establish infection by feeding viral DNA. Furthermore, we found that the ability of PY DNA to induce tumors is enhanced by cleavage of the viral DNA with R-EcoRI, a restriction enzyme which cleaves PY DNA once (15) at a point near the middle of the early region of the viral genome (21 
RESULTS
Susceptibility of mice to infection by PY administered by various routes. The effect of the route of administration of PY virions on the efficiency of infection of mice has been studied in some detail (32) . As a preliminary study in the present work, we have repeated some of these tests and examined additional methods of virus administration. Serial dilutions of PY(LP) virions were inoculated by various routes, and the sera were tested for HI antibody. The mean infective dose (IDi,o; the dilution of virus at which 50% of the mice would be infected) was calculated by the method of Reed and Muench (22, 30) . As shown in Table 1 Table 2 , intranasally administered PY DNA I also did not lead to infection.
Pancreatic DNase-treated PY DNA did not evoke HI antibody production in any of the animals inoculated (Table 2) .
To further define the biological activity of PY DNA in mice, we evaluated the infectivity of different physical forms of viral DNA (Table 4) . The relaxed circular form (DNA II) of PY DNA was nearly as infectious as the supercoiled form, whereas full-length linear forms of viral DNA (DNA I cleaved with the single-cut restriction endonuclease R.BamHI or R.EcoRI) retained 15 to 25% of the infectivity detennined for DNA I.
Tumorigenicity of PY virions in newborn hamsters. In addition to examining the tumorigenicity of PY(LP), which was used in the mouse experiments described above, we also evaluated the T strain of PY, because of its reported virulence in inducing tumors in hamsters (35) . Restriction enzyme digest pattems (RHpaI, R * HindII + III, R * BamHI, and REcoRI) of PY(LP) and PY(T) DNA were not detectably different (our unpublished observations).
We determined the 50% tumor dose of PY (LP) and PY(T) to be 3.8 x 10:3 and 7.8 x 103 PFU, respectively. The rapidity of tumor development was related to the amount of virus injected and was similar in the two strains. The tumors that appeared had the gross appearance of characteristic PY hemagiomatous and sarcomatous lesions and were located in the kidneys, liver, intestinal wall, omentum, lungs, and thoracic wall.
Tumorigenicity of PY DNA. The tumori- Development of HI antibodies in hamsters inoculated with PY DNA. One explanation of the tumors appearing in hamsters after parenteral administration of PY DNA is that they resulted as a direct effect of viral DNA inoculation, presumably by a mechanism involving the integration of the input DNA. We also considered the possibility that viral DNA infection resulted in progeny virion production which, in turn, induced the tumors observed. If the latter explanation is correct, the sera from tumor-bearing animals should contain HI antibody.
The sera of 117 hamsters inoculated with PY DNA were examined for the presence of HI antibody. Ten of 76 animals without tumors had measurable serum HI antibody levels (1:20 to 1: 160) 3 to 4 months after injection; sera from 5 of 41 tumored hamsters had detectable HI antibody. In another experiment, 12 of 25 nontumored animals had detectable HI antibody 187 days after the injection of 103 to 10' PFU of PY virions. These results indicate that while the HI test is a relatively insensitive assay for virus production in hamsters (29, 31) , the development of antibody cannot be correlated with PY tumor induction.
DISCUSSION
Although a number of investigators have studied the tumorigenicity of viral DNA in animals (3-5, 7, 11, 20, 25, 27, 34) , the ability of viral DNA to initiate productive infection in vivo has received little attention. Our experiments indicate that less-than-nanogram amounts of PY DNA can lead to productive viral infection after parenteral inoculation into mice. This level of infectivity is 2 logs below that reported when mouse cells in culture are infected with PY DNA in the presence of DEAE-dextran (37) . Whereas addition of calcium phosphate to our inoculum did not enhance its infectivity in mice, the efficiency of infection we observed is adequate to allow the use of mice as a model system in certain experiments requiring expression of the PY genome. In particular, the biological activity of recombinant DNA molecules constructed by linking DNA sequences to a vector derived from the PY genome could be studied in mice.
To the extent that studying the activity of (27) with intact PY is presently unclear. It is highly unlikely that our PY DNA preparations contain any virus particles. Purification of the DNA included a Hirt extraction in 0.4% sodium dodecyl sulfate (17) , two dye density equilibrium centrifugations (12, 28) , and a final sedimentation through a 5 to 30% neutral sucrose gradient. Furthermore, the same DNA preparation used to inoculate hamsters was not infectious in mice after DNase treatment (Table  2) .
A possibly important observation was that the tumorigenicity of PY DNA was significantly enhanced by cleavage ofthe viral genome at the R EcoRI site. This enhancement was quite unexpected in view of the location of the R-EcoRI site in the middle of the early gene region of the PY genome (21) . Cleavage at this site would affect the synthesis of PY large T antigen but not PY small t antigen (10) . The hr-t function, required for transformation (10) We thank Shirley Taylor for her excellent secretarial assistance.
